Treating the Diabetic Epidemic Effectively: Pharmacists as Key Contributors to the Cause
Proceedings from an expert roundtable discussion held in Chicago, Illinois
Activity Date: December 2006  — Activity Info: Volume3, (6)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity


To provide pharmacists with up-to-date information about diabetes management services, including the prevention and treatment of diabetes.

This activity is designed for pharmacists with an interest in the treatment of patients with diabetes. No prerequisites required.

The University of Tennessee College of Pharmacy takes responsibility for the content, quality, and scientific integrity of this CE activity. At the conclusion of this activity, the participant should be able to:

  • Describe attributes of a successful diabetes self-management strategy. 
  • Discuss key roles that pharmacists provide as members of the healthcare team in achieving and maintaining optimal glucose levels.
  • Explain comorbidities and complications associated with poor type 2 diabetes mellitus control.
  • Assess the implications of clinical studies to evaluate the effect of glycemic control on cardiovascular disease. 
  • Define the role of the pharmacist in the screening of patients with type 2 diabetes mellitus. 
  • Propose interventions to improve quality of care in addition to achieving early and aggressive control. 
  • Identify the needs of the pharmacist to better care for patients with type 2 diabetes mellitus.

The University of Tennessee College of Pharmacy (UTCOP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) to provide continuing education for pharmacists.

This program is approved for 2 hours of credit (0.2 CEUs) and is sponsored by the University of Tennessee College of Pharmacy, which is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Program #064-000-06-208-H01.
This continuing education activity was produced under the supervision of Glen E. Farr, PharmD, Associate Dean of Continuing Pharmacy Education, University of Tennessee College of Pharmacy.

The estimated time to complete this educational activity:  2 hours.

Release date: December 15, 2006. Expiration date: December 15, 2008.

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of University of Tennessee College of Pharmacy name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

A participant, sponsor, faculty member, or other individual wanting to file a grievance with respect to any aspect of a program sponsored or co-sponsored by the UTCOP may contact the Associate Dean for Continuing Education in writing. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.

This program is supported by an educational grant from Takeda Pharmaceuticals North America, Inc.

Home | Contact Us | View Account | Need Help?